First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence

Leptomeningeal metastasis (LM) from lung cancer has poor prognosis, and effective therapy has not been established. We present the case of a 54-year-old man with LM from lung adenocarcinoma harboring EGFR L858R point mutation, who received osimertinib as first-line therapy. He had previously undergo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int Cancer Conf J
Hauptverfasser: Ono, Yuki, Takada, Kazuki, Osoegawa, Atsushi, Kinoshita, Fumihiko, Oba, Taro, Tsukamoto, Shuichi, Tagawa, Tetsuzo, Oda, Yoshinao, Mori, Masaki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Singapore 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797384/
https://ncbi.nlm.nih.gov/pubmed/33489707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00453-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge